Highest development stage: Phase 3

Development status: Active

Gram-positive activity

Mechanism of Action/Target pathogen: Acute bacterial skin and skin structure infections

Additional information: Preclinical In Vitro and In Vivo Absorption Evaluation Of Ozenoxacin (GF-001001-00): A Novel Topical Non-Fluorinated Quinolone.
By: Santos, B.; Albet, C.; Orriols, A.; et al.